"In addition to producing three types of intravenous drugs for the thalassemia patients, the oral type of the same drugs for these patients as well as an effervescent tablet have come on production in the country," Rezazadeh told FNA on Sunday.
He said that the oral type of the thalassemia drug is being produced in Iran both under the license of the main foreign company as well as an Iranian company in the Central city of Saveh.
Iran has taken wide strides in science and technology, particularly in medical and medicinal fields, in recent years.
In August, former Iranian Health Minister Marzieh Vahid Dastjerdi boasted the country's astonishing progress in producing medical tools, equipment and drugs, and said Iran stands 12 in the world ranking of biomedicine production.
"Iran ranks 1st in the region, 4th in Asia and 12th in the world in producing biological drugs," Vahid Dastjerdi said in a ceremony in Tehran at the time to unveil 8 new types of hi-tech medicines used for treating various kinds of diseases.
She also announced that the global exports value of biomedicine industry stands at $1,000bln, and Iran can have a large share of this figure.
